NOTIFICATION
Addendum
The following communication, dated 16 July
2025, is being circulated at the request of the delegation of Canada.
_______________
Title: Notice of
intent: Revisions to the Prescription Drug List for nicotine buccal pouches
Description: The purpose of this notice of intent
is to announce that Health Canada will revise the qualifier of the
"Nicotine or its salts" listing on the human use part of the
Prescription Drug List (PDL). The intent is to clarify the non-prescription status
of nicotine buccal pouches by: amending part "d" of the qualifier of
the listing to be specific to sprays and inhalers only and adding a new part
"f" to the qualifier that is specific to nicotine buccal pouches. The
wording of the qualifier has not changed from that proposed in the 13 February
2025 Notice of Consultation, notified under _G/TBT/N/CAN/741. This revision will be in effect six months from the date
that the Notice of Intent is posted on the Health Canada website.
__________
[1] This information can be provided by including a website address, a
pdf attachment, or other information on where the text of the final/modified
measure and/or interpretive guidance can be obtained.